Rate of bicycle-related fatalities significantly lower in states with helmet laws
Legislation can be vital in helping parents adhere to best practices
2013-05-23
(Press-News.org) Boston, Mass, May 23, 2013— Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent decrease in deaths and injuries for children younger than 16 who were in bicycle-motor vehicle collisions.
The cross-sectional study, conducted by William P. Meehan III, MD, Lois K. Lee, MD, MPH, Rebekah C. Mannix, MD, MPH of Boston Children's Hospital, and Christopher M. Fischer, MD, of Beth Israel Deaconess Medical Center, was published in the Journal of Pediatrics, and suggests that having these laws may influence parents to require their children wear helmets.
"Past research shows that laws can be an important factor in helping parents adhere to best practice guidelines," says Meehan. "For parents who feel like there is conflicting information related to child health, this evidence supports the fact that helmets save lives and that helmet laws play a role."
On average, 900 people die annually in bicycle-motor vehicle collisions—three quarters die from head injuries. At the start of the 12-year study (1999 to 2010), 16 states had bike helmet laws, and 35 did not. The researchers identified all relevant fatalities, totaling 1612, in states with and without bike helmet laws.
After adjusting for factors previously associated with rates of motor vehicle fatalities (elderly driver licensure laws, legal blood alcohol limit and household income) the adjusted fatality rate was still significantly lower in states with helmet laws.
To conduct the retrospective study, researchers analyzed data obtained from the Fatality Analysis Reporting System (FARS)—a census, compiled by the National Highway Traffic Safety Administration, which included information from all 50 states, including the District of Columbia and Puerto Rico.
Since the FARS database is limited to injuries sustained during a motor vehicle collision that resulted in the death of at least one person within 30 days of the collision, the findings are likely an understatement of how important helmet laws are. "As a result of the data only capturing deaths, rather than all injuries, our findings likely underestimate the effects of the mandatory helmet laws, because we did not capture all pediatric bicycle-related injuries," says Mannix.
The American Academy of Pediatrics recommends that all cyclists wear helmets that fit properly for each ride, and supports legislation that requires all cyclists to wear helmets.
###
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395 bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2013-05-22
Boston, MA – New research from Brigham and Women's Hospital (BWH) finds that a genetic risk factor for pulmonary fibrosis, an uncommon but deadly lung disease, may be effective in identifying individuals at risk for this disease. These findings will be presented at the American Thoracic Society International Conference and publish online simultaneously at the New England Journal of Medicine on May 22 and will appear in the July 4, 2013 print edition.
"While this variant of the MUC5B gene is fairly common, pulmonary fibrosis is not. Our findings suggest that pulmonary ...
2013-05-22
Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.
The study findings are reported in the British Medical Journal today and involved researchers at eight other centres in Australia, Oxford University, and the International Agency for Research on Cancer in Lyon, France.
Professor Mathews said: "CT scans were very useful in providing detailed three dimensional pictures to diagnose or exclude disease in internal ...
2013-05-22
21 May 2013, Paris, France: Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI).
European and US NSTE-ACS guidelines currently recommend bivalirudin alone as an alternative to unfractionated heparin plus GP IIb/IIIa receptor inhibitors in patients undergoing an intended urgent or early invasive strategy.
Researchers ...
2013-05-22
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, account for nearly 7 percent of medication errors in hospitalized patients.
With health care organizations facing greater pressure to ensure the safe and effective use of anticoagulants, new guidelines have been developed by a panel of health care experts led by Edith Nutescu, clinical pharmacy professor at the University of Illinois at Chicago and ...
2013-05-22
21 May 2013, Paris, France: The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
DESolve (Elixir Medical Corporation) is the first bioresorbable PLLA-based polymer scaffold that releases novolimus, a major metabolite of sirolimus. "The degradation time is about one year," explained the lead study author Alexandre Abizaid, Director of Interventional Cardiology at Institute ...
2013-05-22
"We spent 15 percent of home energy on gadgets in 2009, and we're buying more gadgets all the time," says Peter Fischer of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab). Fischer lets you know right away that while it's scientific curiosity that inspires his research at the Lab's Advanced Light Source (ALS), he intends it to help solve pressing problems.
"What we're working on now could make these gadgets perform hundreds of times better and also be a hundred times more energy efficient," says Fischer, a staff scientist in the Materials ...
2013-05-22
UCLA life scientists provide important new details on how climate change will affect interactions between species in research published online May 21 in the Journal of Animal Ecology. This knowledge, they say, is critical to making accurate predictions and informing policymakers of how species are likely to be impacted by rising temperatures.
"There is a growing recognition among biologists that climate change is affecting how species interact with one another, and that this is going to have very important consequences for the stability and functioning of ecosystems," ...
2013-05-22
Irvine, Calif., May 22, 2013 – Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society.
After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy and at dramatically lower cost. The same technology could potentially be used for bladder and multiple myeloma cancers, ...
2013-05-22
ATS 2013, PHILADELPHIA ─More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease.
"While there have been many studies of the under-diagnosis of COPD, there has not been a U.S.-based study that has quantified the problem of over-diagnosis," said Christian Ghattas, MD., MSc, a second-year medical resident at Saint Elizabeth Health Center in Youngstown, Ohio, who will present ...
2013-05-22
Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing further animal testing in preparation for possible clinical trials in cocaine addicts, the researchers say.
"It was remarkably serendipitous that when we learned which brain pathway cocaine acts on, we already knew of a compound, CGP3466B, that blocks that specific pathway," says Solomon Snyder, M.D., a professor of neuroscience ...
LAST 30 PRESS RELEASES:
[Press-News.org] Rate of bicycle-related fatalities significantly lower in states with helmet laws
Legislation can be vital in helping parents adhere to best practices
